Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5601)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$595.80
Total Value
$190.66K
Shares Held After
41,713
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$594.61
Total Value
$237.84K
Shares Held After
42,033
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$593.83
Total Value
$142.52K
Shares Held After
42,433
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$592.19
Total Value
$71.06K
Shares Held After
42,673
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
602
Price
$591.24
Total Value
$355.93K
Shares Held After
42,793
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,068
Price
$590.32
Total Value
$630.46K
Shares Held After
43,395
% of Holdings
2.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,734
Price
$589.18
Total Value
$1.02M
Shares Held After
44,463
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,790
Price
$588.33
Total Value
$1.05M
Shares Held After
46,197
% of Holdings
3.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,346
Price
$587.34
Total Value
$790.56K
Shares Held After
47,987
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
354
Price
$586.07
Total Value
$207.47K
Shares Held After
49,333
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
86
Price
$584.80
Total Value
$50.29K
Shares Held After
49,687
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$583.40
Total Value
$93.34K
Shares Held After
49,773
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$581.74
Total Value
$46.54K
Shares Held After
49,933
% of Holdings
0.2%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
971,091
Price
$6.50
Total Value
$6.31M
Shares Held After
26,975,505
% of Holdings
3.6%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
385,442
Price
$1.25
Total Value
$481.80K
Shares Held After
9,778,988
% of Holdings
3.9%
SOLENO THERAPEUTICS INC (SLNO)
Huang Michael F. — Sr. VP of Clinical Development
Shares
488
Price
$31.72
Total Value
$15.48K
Shares Held After
39,823
% of Holdings
1.2%
SOLENO THERAPEUTICS INC (SLNO)
Huang Michael F. — Sr. VP of Clinical Development
Shares
1,838
Price
$31.04
Total Value
$57.05K
Shares Held After
40,311
% of Holdings
4.4%
SOLENO THERAPEUTICS INC (SLNO)
Huang Michael F. — Sr. VP of Clinical Development
Shares
4,256
Price
$30.04
Total Value
$127.84K
Shares Held After
42,149
% of Holdings
9.2%
SOLENO THERAPEUTICS INC (SLNO)
Manning Meredith — Chief Commercial Officer
Shares
558
Price
$31.72
Total Value
$17.70K
Shares Held After
64,507
% of Holdings
0.9%
SOLENO THERAPEUTICS INC (SLNO)
Manning Meredith — Chief Commercial Officer
Shares
2,100
Price
$31.04
Total Value
$65.18K
Shares Held After
65,065
% of Holdings
3.1%
SOLENO THERAPEUTICS INC (SLNO)
Manning Meredith — Chief Commercial Officer
Shares
4,864
Price
$30.04
Total Value
$146.10K
Shares Held After
67,165
% of Holdings
6.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
16,322
Price
$13.48
Total Value
$220.02K
Shares Held After
464,554
% of Holdings
3.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
2,738
Price
$12.49
Total Value
$34.20K
Shares Held After
480,876
% of Holdings
0.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$450.95
Total Value
$1.05M
Shares Held After
33,076
% of Holdings
6.6%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
17,470
Price
$4.75
Total Value
$82.98K
Shares Held After
514,621
% of Holdings
3.3%
Mineralys Therapeutics, Inc. (MLYS)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
310,700
Price
$23.67
Total Value
$7.35M
Shares Held After
5,767,221
% of Holdings
5.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$534.50
Total Value
$85.52K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$533.85
Total Value
$234.89K
Shares Held After
40,673
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$532.50
Total Value
$383.40K
Shares Held After
41,113
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
634
Price
$531.32
Total Value
$336.85K
Shares Held After
41,833
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
903
Price
$530.45
Total Value
$478.99K
Shares Held After
42,467
% of Holdings
2.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
841
Price
$529.09
Total Value
$444.96K
Shares Held After
43,370
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
326
Price
$528.30
Total Value
$172.23K
Shares Held After
44,211
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
314
Price
$527.30
Total Value
$165.57K
Shares Held After
44,537
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
104
Price
$526.27
Total Value
$54.73K
Shares Held After
44,851
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,338
Price
$524.80
Total Value
$702.18K
Shares Held After
44,955
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,809
Price
$523.88
Total Value
$947.69K
Shares Held After
46,293
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,514
Price
$522.98
Total Value
$791.80K
Shares Held After
48,102
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$522.10
Total Value
$207.28K
Shares Held After
49,616
% of Holdings
0.8%
Immunome Inc. (IMNM)
SIEGALL CLAY B — Director
Shares
25,450
Price
$19.67
Total Value
$500.60K
Shares Held After
690,704
% of Holdings
3.7%
IMPACT BIOMEDICAL INC. (IBO)
Macko Todd D — Chief Financial Officer
Shares
43,400
Price
$0.56
Total Value
$24.37K
Shares Held After
155,122
% of Holdings
21.9%
Wave Life Sciences Ltd. (WVE)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
2,495,623
Price
$6.43
Total Value
$16.05M
Shares Held After
26,004,414
% of Holdings
9.6%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
1,973
Price
$37.13
Total Value
$73.26K
Shares Held After
2,188,935
% of Holdings
0.1%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
30,176
Price
$36.38
Total Value
$1.10M
Shares Held After
2,190,908
% of Holdings
1.4%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
30,401
Price
$35.42
Total Value
$1.08M
Shares Held After
2,221,084
% of Holdings
1.4%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
6,735
Price
$30.98
Total Value
$208.64K
Shares Held After
9,597
% of Holdings
41.2%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
9,623
Price
$30.98
Total Value
$298.10K
Shares Held After
16,332
% of Holdings
37.1%
GILEAD SCIENCES, INC. (GILD)
O'Day Daniel Patrick — Director
Shares
10,000
Price
$136.82
Total Value
$1.37M
Shares Held After
642,567
% of Holdings
1.5%
LABCORP HOLDINGS INC. (LH)
Meltzer Jonathan C — EVP, Operations
Shares
839
Price
$267.05
Total Value
$224.05K
Shares Held After
3,620
% of Holdings
18.8%
CHEMED CORP (CHE)
MCNAMARA KEVIN J — Director
Shares
1,500
Price
$369.37
Total Value
$554.05K
Shares Held After
92,219
% of Holdings
1.6%
Showing 351–400 of 5601 transactions (page 8 of 113)